For which group of patients is treatment for asymptomatic bacteriuria recommended?

Treatment for asymptomatic bacteriuria is specifically recommended for pregnant women and individuals undergoing invasive urologic procedures due to the unique risks associated with these populations.

In pregnant women, the presence of asymptomatic bacteriuria can lead to complications, such as increased risk of urinary tract infections (UTIs) that can result in adverse pregnancy outcomes, including preterm labor and low birth weight. Therefore, screening for and treating asymptomatic bacteriuria in this group is an important preventive measure to ensure maternal and fetal health.

For patients undergoing invasive urologic procedures, such as surgery involving the kidneys or bladder, the presence of asymptomatic bacteriuria can increase the risk of postoperative infections. In these cases, treatment is recommended to reduce the potential risk of complications associated with the procedure.

While chronic kidney disease, recurrent urinary tract infections, or age-related considerations for men may necessitate careful management of urinary health, they do not require treatment of asymptomatic bacteriuria unless there are additional symptoms or complications present. Thus, the focus on pregnant women and those undergoing invasive procedures highlights the need for targeted interventions in specific at-risk groups to prevent worsening health outcomes.